Culturepublished

Radiology Holds Three-Quarters of Cleared Medical AI—and a New Veto Problem

The central challenge is no longer whether image-reading systems can find abnormalities. It is whether clinicians can recognize the rare cases where a highly accurate system is wrong without ignoring the cases where it sees something they miss.

By 4 min read
Radiology Holds Three-Quarters of Cleared Medical AI—and a New Veto Problem

Listen to this story

The audio brief

About 1:44
0:001:44
Read transcript
About three-quarters of the roughly 1,400 artificial-intelligence medical devices cleared by the Food and Drug Administration by early 2026 were built for radiology. That concentration points to the real challenge: not replacing radiologists, but training them to veto systems that can be excellent on one task and strangely wrong on another. These tools can draft reports, flag urgent images, detect abnormalities, identify tumor subtypes, and trace lesion boundaries. They can also improve performance in defined settings. An analysis of 43 colonoscopy trials, for example, found that AI-assisted procedures detected more polyps than conventional procedures. But a higher average score does not tell a clinician when to trust the machine. Imagine an AI system detecting 95 percent of lung nodules while radiologists detect 90 percent. The combined team is valuable only if each catches cases the other misses. If a doctor overweights a false positive, that is automation bias. If they fail to challenge a false negative, that is automation complacency. And a cited study found that incorrect AI predictions substantially reduced experienced radiologists’ accuracy on mammograms. The safeguards therefore have to be specific: tool-by-tool failure guidance, confidence estimates, monitoring of disagreements, and training. Yet a 2026 American Medical Association survey found that more than one-quarter of physicians had no AI training, while only 11 percent reported extensive training. The unresolved question is whether clinical systems can preserve complementary human and machine errors as these tools multiply.

Story brief

3 key points

By early 2026, the FDA had cleared roughly 1,400 AI-enabled medical devices, with about 75% focused on radiology—making oversight capability, not replacement, the market’s central constraint. AI can improve performance in defined tasks, but opaque and non-overlapping errors create risks of automation bias and complacency. A 2026 AMA survey found more than one-quarter of physicians had no AI training. Vendors and...

  1. 01

    About 75% of roughly 1,400 FDA-cleared AI-enabled medical devices targeted radiology by early 2026.

  2. 02

    A 43-trial colonoscopy analysis found AI-assisted procedures detected more polyps than conventional procedures in defined settings.

  3. 03

    Incorrect AI predictions substantially reduced experienced radiologists’ mammography accuracy in a cited study.

Radiologists are not being displaced by AI image readers. They are being asked to become the final check on systems that may outperform them on some tasks, yet still make unfamiliar mistakes that can be hard to explain or detect. That is a demanding safety role, not a ceremonial one.

Radiology is the clearest current concentration of medical AI: about three-quarters of roughly 1,400 AI-enabled medical devices cleared by the Food and Drug Administration by early 2026 were designed for the specialty. These tools can draft reports, flag images needing urgent attention, detect abnormalities, identify tumor subtypes, and trace lesion boundaries.

That reality is far from the replacement forecast Geoffrey Hinton made in 2016, when he predicted computers would replace radiologists within five years. Radiology employment has continued to grow instead. But the failed forecast does not mean the technology is marginal: AI-assisted systems can improve detection in defined settings, including colonoscopy, where an analysis of 43 clinical trials found more polyps detected than with conventional procedures.

The work shifts from reading to judging

The safety problem comes from a mismatch in strengths. Neural-network image systems can examine every pixel and compare an image with patterns learned from prior examples. They generally do not show clinicians the reasoning behind an output, however. A radiologist must therefore decide when to accept or reject a conclusion from a system whose path to that conclusion is opaque.

Average accuracy alone cannot settle that decision. In an illustrative example, an AI tool detects 95% of lung nodules and radiologists detect 90%; the radiologists may still catch some nodules the tool misses because human and machine errors are not identical. The value of the combined system depends on preserving those complementary catches, rather than treating the higher headline score as a mandate to defer.

Two ways oversight can fail

  • Automation bias: a clinician gives excessive weight to an AI result, including a false positive that identifies disease where none exists.
  • Automation complacency: a clinician fails to challenge a false negative, such as an AI system missing blood in a brain scan.

Training is part of the clinical system

The risk is not theoretical. A cited study found that experienced radiologists’ mammography accuracy dropped substantially when incorrect AI predictions influenced their decisions. The failure can also run in the other direction: a conspicuously silly AI error may lead a clinician to dismiss a system too broadly, including when it has found a genuine abnormality.

That makes generic instructions to “use AI responsibly” inadequate. Clinicians need to know an individual tool’s reliability and the conditions in which it fails, such as scans degraded by patient movement. Nina Kottler, chief medical AI officer at Mosaic Clinical Technologies, also argues that systems should provide a confidence estimate with each evaluation rather than only a yes-or-no answer, because no radiologist can retain the limits of multiple tools from memory.

Radiology’s lesson is less that humans must remain in the loop than that the loop must be designed. Monitoring when physicians agree or disagree with AI, teaching known failure modes, and giving them information calibrated to a specific result are proposed ways to make that collaboration safer. How to optimize the human-machine team remains unsettled, even as the number and complexity of these systems continue to increase.

Editorial analysis

Our Read

Radiology is becoming an early test of what safe AI augmentation actually demands from a profession. FDA clearances show the category is already concentrated there, while the mammography finding shows that putting a person in the loop is not enough on its own. The next evidence worth watching is whether hospitals measure clinicians’ agreement with AI, train them on known failure modes, and provide usable confidence signals for individual results. Those operational choices may determine whether AI improves diagnosis or merely changes how errors enter the workflow.

Sources

  1. knowablemagazine.orgAI won’t replace radiologists, but it will dramatically change their jobs